The IBN SINA Pharmaceutical Industry Ltd. reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported sales was BDT 2,162.58 million compared to BDT 1,880.85 million a year ago. Net income was BDT 186.07 million compared to BDT 154.44 million a year ago.
For the six months, sales was BDT 4,527.84 million compared to BDT 3,607.5 million a year ago. Net income was BDT 327.88 million compared to BDT 255.86 million a year ago. Basic earnings per share from continuing operations was BDT 10.49 compared to BDT 8.19 a year ago.